Regulation of cell proliferation and survival: Convergence of protein kinases and caspases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Regulation of cell proliferation and survival: Convergence of protein kinases and caspases

Published:2010-03 Issue:3 Volume:1804 Page:505-510
ISSN:1570-9639
Container-title:Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics

Author:

Duncan James S.,Turowec Jacob P.,Vilk Greg,Li Shawn S.C.,Gloor Gregory B.,Litchfield David W.

Funder

Canadian Cancer Society Research Institute

Canadian Institutes of Health Research (CIHR)

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics,Analytical Chemistry

Reference83 articles.

1. Protein kinases—the major drug targets of the twenty-first century?;Cohen;Nat. Rev. Drug. Discov.,2002

2. Protein kinase inhibitors: insights into drug design from structure;Noble;Science,2004

3. Opportunities and challenges in the development of kinase inhibitor therapy for cancer;Sawyers;Genes. Dev.,2003

4. The druggable genome;Hopkins;Nat. Rev. Drug. Discov.,2002

5. Applying the discovery of the Philadelphia chromosome;Sherbenou;J. Clin. Invest.,2007

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serine/Threonine Protein Kinases as Attractive Targets for Anti-Cancer Drugs—An Innovative Approach to Ligand Tuning Using Combined Quantum Chemical Calculations, Molecular Docking, Molecular Dynamic Simulations, and Network-like Similarity Graphs;Molecules;2024-07-05

2. Recent Advances in the Discovery of CK2 Inhibitors;ACS Omega;2024-05-03

3. Regulation of cancer progression by CK2: an emerging therapeutic target;Medical Oncology;2024-03-25

4. CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy;Cancer Letters;2024-03

5. Casein kinase (CK) inhibitors;Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3